Immunogenicity of COVID ‐19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy
Summary: Immune responses to primary COVID‐19 vaccination were investigated in 58 patients with follicular lymphoma (FL) as part of the PETReA trial of frontline therapy (EudraCT 2016–004010‐10). COVID‐19 vaccines (BNT162b2 or ChAdOx1) were administered before, during or after cytoreductive treatmen...
मुख्य लेखकों: | Lim, YJ, Ward, V, Brown, A, Phillips, E, Kronsteiner, B, Malone, T, Jennings, D, Healy, S, Longet, S, James, T, Thomson, P, Farrell, L, Oates, M, Jackson, R, Morrison, A, Burns, M, Carroll, M, Klenerman, P, Turtle, L, Naisbitt, D, Rhodes, M, Robinson, K, Gatto, S, Young, M, Eyre, TA, Eyre, DW, Dunachie, S, Barnes, E |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
Wiley
2024
|
समान संसाधन
-
P1095: COVID-19 VACCINE RESPONSES IN FOLLICULAR LYMPHOMA: DETERMINANTS OF HUMORAL AND CELLULAR IMMUNITY IN THE PETREA TRIAL OF FRONTLINE CHEMOIMMUNOTHERAPY
द्वारा: Yeong Jer Lim, और अन्य
प्रकाशित: (2023-08-01) -
Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma
द्वारा: Reid W. Merryman, और अन्य
प्रकाशित: (2023-02-01) -
Follicular Lymphoma in Chile in the Adult Public Cancer Program: The Impact of Chemoimmunotherapy
द्वारा: María Elena Cabrera, और अन्य
प्रकाशित: (2024-09-01) -
Symptomatic Follicular Lymphoma: Complete Remission After Chemoimmunotherapy with Bendamustine–Rituximab
द्वारा: Wulyo Rajabto, और अन्य
प्रकाशित: (2024-04-01) -
Two Follicular Dendritic Cell Sarcoma (FDCS) patients treated with Chemoimmunotherapy
द्वारा: Berksoy Sahin, और अन्य
प्रकाशित: (2024-05-01)